Results 291 to 300 of about 198,438 (310)

Migraine

BMJ, 1949
openaire   +1 more source

Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS): a randomised, double-blind, placebo-controlled, phase 3b trial

Lancet, The, 2019
Michel D Ferrari, Andrew H Ahn, Hans-Christoph Diener   +2 more
exaly  

Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine

Lancet, The, 2005
Martin Dichgans, Michel D Ferrari, Michael Pusch   +2 more
exaly  

Migraine Versus Probable Migraine

Headache: The Journal of Head and Face Pain, 2006
Randolph W, Evans, Seymour, Solomon
openaire   +2 more sources

Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study

Lancet, The, 2018
Uwe Reuter, Peter Goadsby, Michel Lantéri-Minet   +2 more
exaly  

Migraine

Lancet, The, 2004
Stephen D Silberstein
exaly  

Migraine

New England Journal of Medicine, 2017
openaire   +4 more sources

Targeting calcitonin gene-related peptide: a new era in migraine therapy

Lancet, The, 2019
Andrew Charles, Patricia Pozo-Rosich
exaly  

MIGRAINE

Journal of the American Medical Association, 1955
openaire   +2 more sources

Chronic migraine: risk factors, mechanisms and treatment

Nature Reviews Neurology, 2016
Arne May
exaly